Clinical Trial

SAFER Karachi - A Fall Prevention Intervention

Study acronym: SAFER
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 9, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this pilot study is to evaluate the feasibility, acceptability, and short-term effects of a culturally adapted and strengthened fall prevention program in older adults aged 60 years and above living in urban Karachi, Pakistan. The study aims to understand whether a structured, community-based intervention can improve mobility, confidence, and overall well-being, while reducing the risk of falls. The main questions it aims to answer are: 1. Is the adapted and strengthened fall prevention program feasible and acceptable for older adults in Karachi? 2. Does participation in the program improve mobility, balance, fall-related self-efficacy, and emotional well-being among participants? Participants will: 1. Take part in a 7-week group-based fall prevention program that includes strength and balance exercises, home safety education, medication awareness, and behavioural strategies 2. Receive a follow-up home visit to reinforce safety practices and environmental modifications 3. Attend a booster session after 3 months to support continued engagement 4. Complete assessments at baseline and follow-up, including mobility, cognitive function, quality of life, and emotional well-being 5. Maintain monthly fall logs to report any fall incidents during the study period
Protocol Amendment History 1 change
notable Primary completion pushed: 2026-04 -> 2026-06-30 2026-06-10
Trial Details
NCT Number NCT07504237
Lead Sponsor Aga Khan University
Collaborators: Fogarty International Center of the National Institute of Health
Conditions Accidental Falls, Falls, Falls Injury, Mobility Difficulty, Mobility and Independence, Aged 60 Years or Older
Enrollment 75 participants
Start Date 2025-09-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-06-09